PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

NCT00364013 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1183

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Panitumumab
DRUG: FOLFOX regimen

Sponsor

Amgen